Salute e Benessere

Home Healthcare Market to Value USD 786.85 Billion by 2032 | Precedence Research

Home healthcare is a wide range of medical and non-medical services offered to patients in their homes. These services are short-term or long term offered by skilled professionals, including registered nurses, licensed practical nurses, occupational therapists, social workers, and home health aides. Home healthcare is a wide range of medical and non-medical services offered to patients in their homes. These services are short-term or long term offered by skilled professionals, including...
PR Newswire
23/11/2023

Ellipses EP0031/A400 granted Orphan Drug Designation from the US Food and Drug…

The FDA grants ODD for investigational treatments for rare diseases, such as RET fusion-positive solid tumours, defined as affecting fewer than 200,000 people in the United States. ODD qualifies the developer for certain incentives with the goal of accelerating drug development for patients, including tax credits and seven years of market exclusivity in the US upon approval by the FDA. The FDA grants ODD for investigational treatments for rare diseases, such as RET fusion-positive solid...
PR Newswire
23/11/2023

Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule

ECLIPSE is a Phase 3, multi-center, open-label, randomized clinical trial comparing the safety and efficacy of 177Lu-PSMA I&T versus hormone therapy in patients with metastatic castration-resistant prostate cancer. The ECLIPSE trial enrolled over 400 patients, ahead of schedule, across 51 trial sites in the United States and Europe. Sakir Mutevelic, MD, MSc, Chief Medical Officer at Curium said:“We are proud to announce the completion of enrollment in the ECLIPSE trial, and would...
Nasdaq GlobeNewswire
23/11/2023

Attend the Healthcare Innovation Summit Africa 2023

Even more notable is the impact of data in healthcare and how it is helping to solve the most challenging problems in patient health and operational efficiency. Even more notable is the impact of data in healthcare and how it is helping to solve the most challenging problems in patient health and operational efficiency. InJanuary 2023, Harvard Business Review Analytic Services conducted a global survey of 757 members of the Harvard Business Review audience who work in the health care...
PR Newswire
23/11/2023

Non-Injectable Insulin Sales to Surge at 9.50% CAGR by 2034, Fueled by R&D and…

The non-injectable insulin market is projected to generate US$ 1372.9 million in 2024. According to projections, the market will reach US$ 4,418.70 million in 2034. Between 2023 and 2033, the market is expected to register a CAGR of 9.50%. Pharmaceutical companies and researchers strive to offer more convenient alternatives to traditional insulin injections, the market for non-injectable insulin has seen notable growth in recent years. With products like Afrezza, inhaled insulin offers…
PR Newswire
23/11/2023

Trillium Health Partners to become first in Canada to deploy AI in diagnostic…

"This technology will enable THP to expedite the diagnosis and treatment of potentially fatal conditions where every minute counts for improved patient outcomes," says Dr. Ivan Diamond, Program Chief and Medical Director Diagnostic Imaging, Trillium Health Partners. "We are proud to be the first Canadian adopter of this cutting-edge technology, which has the potential to reinvent how care is delivered within our walls and beyond. Using the Sectra Amplifier Service to deploy this…
PR Newswire
23/11/2023

MAXIMA GRUPĖ ANNOUNCES HEADQUARTERS ADDRESS CHANGE

MAXIMA GRUPĖ, UAB informs about the changed registered and correspondence address. The company's registered address at Savanorių pr. 5 is being changed to Ozo g. 25, LT-07150, Vilnius. AdditionalInformation "Maxima Grupė" manages retail chains "Maxima" (in the Baltic countries), "Stokrotka" (in Poland), "T-Market" (in Bulgaria), and the online food store "Barbora," operating in the Baltic countries and Poland. "Maxima Grupė" is part of…
Nasdaq GlobeNewswire
23/11/2023

MC2 Therapeutics Announces First Patients Enrolled in Phase 2 Proof of Concept…

MC2 Therapeutics Announces First Patients Enrolled in Phase 2 Proof of Concept Clinical Trial in Vulvar Lichen Sclerosus MC2-25 VLS is a first-in-class drug candidate for urea associated skin diseases using a di-peptide as an iso-cyanate scavenger to inhibit carbamylation of amino acids and proteins in the skinMC2-25 VLS has the potential to become the first approved treatment for Vulvar Lichen Sclerosus (VLS), a debilitating chronic inflammatory disorder thought to affect millions of...
Nasdaq GlobeNewswire
23/11/2023

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host…

Geneva, Switzerland, November 23, 2023 - Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that that it will issue its Third Quarter 2023 Financial Results on November 29, 2023. Tim Dyer, CEO, Robert Lütjens, Head of Discovery – Biology and Mikhail Kalinichev, Head of Translational Science, will provide a business update and a review of the Addex product pipeline during...
Nasdaq GlobeNewswire
23/11/2023

Nights On Lottie 2023: £1000+ Gifts Exclusively For UK Carers & Care Workers To…

Last year, Lottie launched the first Night's On Lottie, supported by The Care Workers Charity and endorsed by Strictly Come Dancing judge Anton Du Beke, giving away 1000s of free night stays exclusively to carers nationwide. Last year, Lottie launched the first Night's On Lottie, supported byThe Care Workers Charityand endorsed by Strictly Come Dancing judge Anton Du Beke , giving away 1000s of free night stays exclusively to carers nationwide. Lottie's latest research has found...
PR Newswire
23/11/2023

Multiplex Assay Market to Reach $7.7 Billion, Globally, by 2032 at 7.8% CAGR…

Request Sample of the Report on Multiplex Assay Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/1921 Request Sample of the Report on Multiplex Assay Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/1921 Prime determinants of growth Rise in prevalence of chronic and infectious diseases, technological advancement in multiplex assay products, rise in adoption of personalized medicines drive the growth of the global multiplex assay...
PR Newswire
23/11/2023

EirGenix's Breast Cancer Biosimilar Receives Marketing Authorization by EC

The impact of both breast and gastric cancer in Europe is significant. Each year, over 355,000 women are diagnosed with breast cancer, and with 92,000 deaths per year, it is the number one cause of cancer death among women. Gastric cancer is the sixth most common of all cancer types and with 107,000 deaths annually it is the fourth most common cause of cancer-related death in Europe. In up to 20% of breast cancers and up to 30% of gastric cancers diagnosed, a HER2 protein overexpression (or HER2…
PR Newswire
23/11/2023

Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results…

the Lancet Infectious Diseases.The paper presents final analysis results from a multicenter, double-blind, phase 3, randomized controlled study (NCT05582629) evaluating the efficacy and safety of VV116 (mindeudesivir hydrobromide tablets, product code: VV116/JT001) in patients with mild-to-moderate COVID-19. This study demonstrated that VV116 significantly reduced the time to sustained clinical symptom resolution compared to placebo, with no observed safety concerns. During the study,...
Nasdaq GlobeNewswire
23/11/2023

Untapped Potential: Antibody Discovery Market to Surge to US$17.14 Billion by…

The global antibody discovery market is anticipated to reach a valuation of US$ 7,652.2 million in 2024, driven by the increasing incidence of chronic diseases. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 7.2% between 2024 and 2034 and reaching a total valuation of approximately US$ 17,142.7 million by 2034. The global antibody discovery market is anticipated to reach a valuation ofUS$ 7,652.2 millionin 2024, driven by the increasing...
PR Newswire
22/11/2023

The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma…

DelveInsight has recently released a series of epidemiology-based market reports focusing on B-cell lymphoma including Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma. These reports include a comprehensive understanding of current treatment practices, historical and forecasted patient pool, emerging drugs, market share of individual therapies, and historical and…
PR Newswire
22/11/2023

Artificial Intelligence (AI) in Genomics Market to Surpass US$ 19.72 Billion by…

The increasing volume of genomic data requires advanced analytics, and AI plays a crucial role in deciphering complex genetic informatics quickly and accurately. AI also accelerates drug discovery to identify potential targets, predicts drug responses and streamline the development process, reducing time and cost. Growing awareness among healthcare professionals and the public about the benefits of AI in genomics is augmenting acceptance and demand for AI technologies in the genomics market. ...
PR Newswire
22/11/2023

Ambulatory Surgical Center Market to Surpass US$ 128.28 Billion by 2030 -…

Increasing purchase of management and ownership is gaining traction in the global ambulatory surgical center market. For instance, in October 2021, United Surgical Partners International (USPI) entered into partnership with Compass Surgical Partners for USPI for buying Compass Surgical Partner's management and ownership stakes in nine ambulatory surgery centers (ASCs). This agreement will enable establishment of ASC in the Market around the world. Moreover, growing number of product launches by…
PR Newswire
22/11/2023

Bracco Announces Long-Term Strategic Partnership with ulrich medical for…

Organ and tissue differentiation is frequently only possible with the use of contrast media in medical imaging. For over 30 years, ulrich medical has offered contrast media injectors for use in computed tomography and magnetic resonance imaging. The injector submitted to the FDA is already approved by the European Medicines Agency and commercialized by ulrich medical in the European Union and in numerous other countries around the globe. Organ and tissue differentiation is frequently only...
PR Newswire
22/11/2023

EssilorLuxottica and Moncler announce an exclusive licensing agreement

ESSILORLUXOTTICAAND MONCLERANNOUNCE ANEXCLUSIVE LICENSING AGREEMENT Charenton-le-Pont, France and Milan, Italy (November 22, 2023 – 6:00 pm CET)– EssilorLuxottica and Moncler have announced today the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.The agreement will be in effect from January 2024 until December 2028, with an automatic renewal option for an additional five years. The first Moncler...
Nasdaq GlobeNewswire
22/11/2023

Bavarian Nordic to hold Capital Markets Days in February 2024

COPENHAGEN, Denmark, November 22, 2023– Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in February 2024 for investors and analysts across Europe and the U.S.At these half-day events, the chairman and senior management of Bavarian Nordic will provide an update on the company's strategy as well as a deep dive into its two business areas:travel healthandpublic preparedness, and the opportunities ahead.The capital market days are scheduled the following...
Nasdaq GlobeNewswire
22/11/2023

Population Health Management Market to Record USD 140.99 Billion by 2030…

Get a Sample PDF of the Report: https://www.kingsresearch.com/request-sample/population-health-management-market-237 Get a Sample PDF of the Report:https://www.kingsresearch.com/request-sample/population-health-management-market-237 Competitive Landscape Leading industry participants are emphasizing various strategic approaches, including partnerships, mergers, acquisitions, innovative product development, and collaborative ventures. These endeavours' are aimed at broadening...
PR Newswire
22/11/2023

Print On Demand Market Revenue to Reach USD 39.40 Billion by 2030, Recording a…

Get a Sample PDF of the Report: https://www.kingsresearch.com/request-sample/print-on-demand-market-224 Get a Sample PDF of the Report:https://www.kingsresearch.com/request-sample/print-on-demand-market-224 Competitive Landscape Prominent companies in the global print on demand industry are strategically prioritizing acquisition as a means to broaden their global presence. For instance, HoneyComm, an e-commerce platform specializing in health and wellness, recently announced the...
PR Newswire
22/11/2023

Healthcare Staffing Market Size to Hit USD 50,112 Million by 2032 | Precedence…

The U.S. healthcare staffing market size was valued at USD 23,600 million in 2022 and is anticipated to reach around USD 41,170 million by 2032, growing at a CAGR of 5.7% during the forecast period 2023 to 2032. The U.S. healthcare staffing market size was valued atUSD 23,600 millionin 2022 and is anticipated to reach aroundUSD 41,170 millionby 2032, growing at a CAGR of 5.7% during the forecast period 2023 to 2032. U.S. Healthcare Staffing Market Revenue, By Type, 2022-2032...
PR Newswire
22/11/2023

Hemodialysis Market to Reach $111.8 Billion, Globally, by 2032 at 3.8% CAGR…

Request Sample of the Report on Hemodialysis Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/4660 Request Sample of the Report on Hemodialysis Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/4660 Prime determinants of growth Rise in prevalence of kidney failure and end stage renal disease (ESRD), technological advancement in hemodialysis devices, surge in geriatric population who is vulnerable to kidney failure, and increase in...
PR Newswire
22/11/2023
Altri  Comunicati